Browsing Tag
Forte Biosciences
1 post
VYVGART Sjögren’s setback sends argenx shares lower despite $1.5bn quarterly sales
argenx shares sink after the Phase 3 UNITY failure removes a major VYVGART expansion opportunity despite continued blockbuster sales growth.